silybin has been researched along with Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramanathan, R; Sivanesan, K | 1 |
| Bhavani, G; Ezhilarasan, D; Jesudas, B; Karthikeyan, S; Raghu, R | 1 |
2 other study(ies) available for silybin and Hyperlipemia
| Article | Year |
|---|---|
Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism.
Topics: Adipose Tissue; Animals; Dose-Response Relationship, Drug; Female; Hyperlipidemias; Isoniazid; Lipids; Liver; Male; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Rats; Rats, Wistar; Silybin; Silymarin; Structure-Activity Relationship; Zidovudine | 2017 |
Silibinin mitigates zidovudine-induced hepatocellular degenerative changes, oxidative stress and hyperlipidaemia in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Anti-HIV Agents; Catalase; Chemical and Drug Induced Liver Injury; Fatty Acids, Nonesterified; Female; Hyperlipidemias; Lipid Peroxidation; Liver; Male; Oxidative Stress; Protective Agents; Rats, Wistar; Silybin; Silymarin; Zidovudine | 2015 |